Skip to main content
. 2020 Oct 9;12:9915–9928. doi: 10.2147/CMAR.S273687

Figure 6.

Figure 6

HMGA1 upregulation reverses the impacts of si-VPS9D1-AS1 on CRC cells. (A) Western blotting was used to assess the protein level of HMGA1 in HCT116 and SW480 cells after pcDNA3.1-HMGA1 or pcDNA3.1 introduction. (B, C) pcDNA3.1-HMGA1 or pcDNA3.1, alongside si-VPS9D1-AS1, was transfected into HCT116 and SW480 cells, followed by the measurement of proliferation and apoptosis using CCK-8 and flow cytometry assays. (D, E) Cell migration and invasion assays were performed to determine the migratory and invasive abilities of the cells mentioned above. *P < 0.05 and **P < 0.01.

Abbreviations: HMGA1, high-mobility group AT-hook 1; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; VPS9D1-AS1, VPS9D1 antisense RNA 1; NC, negative control; miR-525-5p, microRNA-525-5p; si-VPS9D1-AS1, small interfering RNA targeting VPS9D1-AS1; si-NC, negative control small interfering RNA; PI, propidium iodide.